Non-executive director Guo Huaqing increased his holdings in SciClone Pharmaceuticals (02171.HK) by 30,000 shares at a price of 15.09 Hong Kong dollars per share.

According to the China Fortune Financial News APP, the latest data from the Hong Kong Stock Exchange shows that on December 19th, non-executive director Guo Huaqing increased his holdings of Geiji Pharmaceutical (02171.HK) by 30,000 shares, with a price of 15.09 Hong Kong dollars per share, totaling 452,700 Hong Kong dollars. After the increase, the latest number of shares held is approximately 226 million, with a shareholding ratio of 39.02%.